RxSight, Inc. Faces Securities Fraud Investigation: DJS Law Group Investigating Claims on Behalf of Investors

The DJS Law Group is investigating claims of securities fraud against RxSight, Inc. (NASDAQ: RXST) for allegedly issuing misleading statements and concealing information from investors. The investigation focuses on the Company's financial performance and guidance for 2025. Shareholders who suffered losses are encouraged to contact the firm for more information.

The DJS Law Group has announced an investigation into potential securities fraud violations committed by RxSight, Inc. (NASDAQ: RXST). The investigation focuses on whether the company issued misleading statements or failed to disclose pertinent information to investors. This probe follows the company's second-quarter 2025 financial results, which revealed declines in key metrics, including sales of Light Delivery Devices (LDD) and total revenue, alongside a downward revision of full-year financial guidance due to "adoption challenges" [1].

On July 9, 2025, RxSight reported a significant drop in its financial performance, attributing the decline to "adoption challenges" that have caused an "LDD stall." This announcement led to a 38% decrease in the company's stock price on the same day. Shareholders who suffered losses are encouraged to contact the DJS Law Group to discuss their rights and potential participation in the investigation [1].

The DJS Law Group specializes in securities class actions, corporate governance litigation, and M&A appraisals. Their clients include some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The firm is known for its balanced counseling and aggressive advocacy, focusing on enhancing investor returns [1].

In addition to the DJS Law Group, other law firms have also issued notices to shareholders of RxSight, Inc. The Gross Law Firm and Glancy Prongay & Murray LLP have both announced pending class action lawsuits against the company, alleging similar violations of securities laws. These lawsuits allege that RxSight issued materially false and misleading statements and failed to disclose critical information, including adoption challenges and overstated demand for its products [2, 3].

Shareholders who purchased shares of RxSight during the class period from November 7, 2024, to July 8, 2025, are encouraged to register for these class actions by September 22, 2025. The Gross Law Firm and Glancy Prongay & Murray LLP have provided contact information and online forms for shareholders to participate [2, 3].

References:
[1] https://www.prnewswire.com/news-releases/rxsight-inc-investigated-for-securities-fraud-violations---contact-the-djs-law-group-to-discuss-your-rights--rxst-302526168.html
[2] https://www.marketscreener.com/news/the-gross-law-firm-reminds-rxsight-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-p-ce7c5edadf8bff2c
[3] https://www.marketscreener.com/news/rxsight-inc-rxst-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-ce7c5edad18cf625